Editorial Board Members’ Collection Series: Physiology and Drug Discovery of Neurodegenerative Diseases
A special issue of Biology (ISSN 2079-7737).
Deadline for manuscript submissions: closed (30 November 2023) | Viewed by 8332
Special Issue Editors
2. Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
Interests: X-ray protein crystallography; enzymology; structure-based drug design
Interests: enzymology; protein chemistry; transglutaminase; gene regulation; oxidative damage
Special Issue Information
Dear Colleagues,
We are pleased to invite you to contribute your work to a Special Issue of Biology entitled “Editorial Board Members’ Collection Series: Physiology and Drug Discovery of Neurodegenerative Diseases”. Neurodegenerative diseases are caused by the progressive loss of neuron structure in the process of neurodegeneration, which ultimately leads to neuron cell death. The major neurodegenerative diseases include Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, multiple sclerosis, Huntington’s disease, multiple-system atrophy, prion diseases, and Friedreich’s ataxia. Since there are currently no methods or treatments that can effectively reverse the progressive degeneration of neurons, these diseases are considered incurable.
The aim of this Special Issue is to collect articles that represent the current knowledge and progress in neurodegenerative diseases for dissemination to the readers, and to promote the progress of the field. In this Special Issue, original research articles and reviews are welcome. Although Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis are the major focuses of this Special Issue, any articles on neurodegenerative diseases are welcome.
We look forward to receiving your contributions.
Prof. Dr. Hengming Ke
Prof. Dr. Carlo M. Bergamini
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neurodegenerative diseases
- Alzheimer’s
- Parkinson’s
- Huntington’s
- amyotrophic lateral sclerosis
- multiple-system atrophy
- prion diseases
- Friedreich’s ataxia